Searcharxiv⌕ Search

arXiv subjects

Eun Jeong Oh

Publications and source records attributed to Eun Jeong Oh.

3 recordsLinked to original sources

Reluctant Transfer Learning in Penalized Regressions for Individualized Treatment Rules under Effect Heterogeneity

Estimating individualized treatment rules (ITRs) is fundamental to precision medicine, where the goal is to tailor treatment decisions to individual patient characteristics. While numerous methods have been developed for ITR estimation, there is limited research on model updating that accounts for shifted treatment-covariate relationships in the ITR setting. In practice, models trained on source data must be updated for new (target) datasets that exhibit shifts in treatment effects. To address this challenge, we propose a Reluctant Transfer Learning (RTL) framework that enables efficient model adaptation by selectively transferring essential model components (e.g., regression coefficients) from source to target data, without requiring access to individual-level source data. Leveraging the principle of reluctant modeling, the RTL approach incorporates model adjustments only when they improve performance on the target dataset, thereby controlling complexity and enhancing generalizability. Our method supports multi-armed treatment settings, performs variable selection for interpretability, and provides a regret bound for the difference in value of the optimal ITR and that of the estimated ITR. Through simulation studies and an application to a real data example from the Best Apnea Interventions for Research (BestAIR) trial, we demonstrate that RTL outperforms existing alternatives. The proposed framework offers an efficient, practically feasible approach to adaptive treatment decision-making under evolving treatment effect conditions.

stat.ME↗

A Network-Guided Penalized Regression with Application to Proteomics Data

Network theory has proven invaluable in unraveling complex protein interactions. Previous studies have employed statistical methods rooted in network theory, including the Gaussian graphical model, to infer networks among proteins, identifying hub proteins based on key structural properties of networks such as degree centrality. However, there has been limited research examining a prognostic role of hub proteins on outcomes, while adjusting for clinical covariates in the context of high-dimensional data. To address this gap, we propose a network-guided penalized regression method. First, we construct a network using the Gaussian graphical model to identify hub proteins. Next, we preserve these identified hub proteins along with clinically relevant factors, while applying adaptive Lasso to non-hub proteins for variable selection. Our network-guided estimators are shown to have variable selection consistency and asymptotic normality. Simulation results suggest that our method produces better results compared to existing methods and demonstrates promise for advancing biomarker identification in proteomics research. Lastly, we apply our method to the Clinical Proteomic Tumor Analysis Consortium (CPTAC) data and identified hub proteins that may serve as prognostic biomarkers for various diseases, including rare genetic disorders and immune checkpoint for cancer immunotherapy.

stat.ME↗

Leveraging Two-Phase Data for Improved Prediction of Survival Outcomes with Application to Nasopharyngeal Cancer

Accurate survival predicting models are essential for improving targeted cancer therapies and clinical care among cancer patients. In this article, we investigate and develop a method to improve predictions of survival in cancer by leveraging two-phase data with expert knowledge and prognostic index. Our work is motivated by two-phase data in nasopharyngeal cancer (NPC), where traditional covariates are readily available for all subjects, but the primary viral factor, Human Papillomavirus (HPV), is substantially missing. To address this challenge, we propose an expert guided method that incorporates prognostic index based on the observed covariates and clinical importance of key factors. The proposed method makes efficient use of available data, not simply discarding patients with unknown HPV status. We apply the proposed method and evaluate it against other existing approaches through a series of simulation studies and real data example of NPC patients. Under various settings, the proposed method consistently outperforms competing methods in terms of c-index, calibration slope, and integrated Brier score. By efficiently leveraging two-phase data, the model provides a more accurate and reliable predictive ability of survival models.

stat.ME↗